VELBAN
LOE ApproachingNDAINJECTIONINJECTABLEPriority Review
Approved
Nov 1965
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Priority Review
Drug data last refreshed 18h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
VELBAN (vinblastine sulfate) is a vinca alkaloid small-molecule injectable approved in 1965 for cancer indications. It functions as a mitotic inhibitor by disrupting microtubule formation, preventing cell division in rapidly dividing cells. The drug is administered intravenously and remains a foundational chemotherapy agent across multiple malignancy types.
LOE Approaching
Product is in late-stage lifecycle with low competitive pressure (30%), indicating potential for portfolio optimization and transition planning rather than growth investment.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on VELBAN as a legacy product offers career value in portfolio management, regulatory maintenance, and operational efficiency—ideal for professionals seeking stability rather than innovation-driven growth. This role typically suits mid-to-late-career professionals managing mature assets or those transitioning to newer launches within Eli Lilly's pipeline.
Product Manager (Legacy)
Worked on VELBAN at Eli Lilly and Company? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.